Coronary Hybrid Revascularisation Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the registry is to assess results of combined operative and catheter based (hybrid procedure) treatment of patients with significant coronary artery disease using essential clinical and angiographic parameters.

Based on existing literature we expect the results of coronary artery bypass grafting of the anterior descendent coronary artery (LAD), segment 1 and 2, using the so-called mammary artery graft, to be superior to stent treatment of the same artery.

At the same time a catheter based intervention using balloon, bare metal stents (BMS) or drug eluting stents (DES) seems to be a better treatment that a saphenous vein graft for other coronary arteries than the LAD. I.e. the right coronary artery (RCA) and the left circumflex coronary artery (CX).

Therefore, we expect a combination of the mentioned surgical and catheter based techniques to be a better treatment than bypass operation or catheter based intervention alone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hybrid Revascularization Versus Coronary Artery Bypass Grafting

NCT05504031

Coronary Artery Disease

NOT_YET_RECRUITING NA

Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease

NCT01035567

Heart Disease Myocardial Ischaemia Coronary Disease +1 more

COMPLETED PHASE2/PHASE3

Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients

NCT05534698

IHD LV Dysfunction

NOT_YET_RECRUITING NA

Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

NCT01443754

Coronary Artery Disease (CAD)

TERMINATED

HYbrid CoronAry Revascularization in DiabeticS

NCT02504762

Diabetes Heart Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 150 consecutive patients will be included in the study. The patients will have a coronary artery narrowing located to the LAD, which can be treated with a mammary graft, and a stenosis located to other coronary arteries (RCA and CX), which can be treated by balloon or stent.

The patients included in the study will be recruited from patients who are referred to the Department of Cardiology/Department of Thoracic Surgery, Aarhus University Hospital, Skejby for treatment of significant coronary artery disease. We will not announce for patients, and the patients will not receive a honorarium for participation.

The first 100 patients will be treated i two seances; operation and stent treatment with few days interval. The last 50 patients will be treated in a hybrid operation room with operation and stent treatment in the same seance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Significant Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Result of combined CABG and PCI treatment

The registry is to assess results of combined operative and catheter based (hybrid procedure) treatment of patients with significant coronary artery disease using essential clinical and angiographic parameters.

Group Type EXPERIMENTAL

Combined CABG and PCI

Intervention Type PROCEDURE

Coronary artery bypass grafting Percutaneous coronary intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combined CABG and PCI

Coronary artery bypass grafting Percutaneous coronary intervention

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stable, unstable angina pectoris and ACS.
* Significant stenosis of LAD, segment 1 or 2 and of other coronary arteries.
* The patient can be treated with a mammary graft to LAD and by balloon or stent of other lesions.
* Signed informed consent must be available.

Exclusion Criteria

* Earlier cardiac surgery
* Treatment with coronary stent within one year.
* ST-elevation infarction within 24 hours.
* Coronary artery lesions located to LAD, segment 1 or 2, which cannot be treated by coronary bypass operation.
* Stenosis of diagonal branches, CX artery and the right coronary artery, which cannot be treated by PCI.
* Expected survival \<1 year following successful treatment.
* Allergy to aspirin, clopidogrel, ticlopidine and/or prasugrel.
* Allergy to sirolimus, everolimus, zotarolimus og biolimus

Known disorder of the bloods ability to coagulate (such as renal failure (dialysis or renal creatinine clearance \< 50ml/min), congenital coagulopathy, needs for anticoagulant treatment before surgery) Previous gastrointestinal bleeding or previous cerebral

Eligible Sex

ALL

Accepts Healthy Volunteers

No